India would be the focus for conducting clinical trials of new drugs developed and would make India a Hub for clinical trials as it has the largest potential of patients and diseases. Pharmaceutical companies say that by 2010 International pharmaceutical companies would invest more than $ 1.5 billion in clinical trials in India. The Indian Science and Technology, Indian Council for Medical Research, Council for Scientific and Industrial Research and Department of Biotechnology have increased their funding to cancer clinical research, mostly involving cancer prevention and early detection.
There would be an increased testing of new drugs on cancer patients in India. In a recent initiative in clinical research a new collaboration has been signed between University of Oxford and GlaxoSmithKline (GSK) for cancer research. This collaboration would start a new network of pharmaceutical industries and clinical oncologist to undertake effective clinical trials in cancer which would help in effective drug discovery.